Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-05 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.990 | 1.620 | 0.6300 | ||||
REV | 54.090M | 69.990M | 15.900M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
LGND | Ligand Pharmaceuticals | 150.21 | 3.87 | 2.64% | 2.5B |
You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Cerevel Therapeutics Hldg (NASDAQ:CERE), OPKO Health (NASDAQ:OPK) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Barclays on 2021-02-04. The analyst firm set a price target for 198.00 expecting LGND to rise to within 12 months (a possible 31.82% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $150.21 last updated Thu Feb 25 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ligand Pharmaceuticals. The last dividend paid out to investors was $NaN on 2007-04-03.
There is no upcoming split for Ligand Pharmaceuticals.